Drug intelligence / Profile preview

Glucotrojan

Development stage
Preclinical
Lead developer
JBA Brands
Modality
Small Molecules
Administration
Oral
01

Overview

**Glucotrojan** is a powdered dietary supplement formulated to support normal glucose metabolism, blood sugar balance, and healthy insulin response[2][5][6]. The supplement contains extracts of white mulberry leaf (Morus alba), mango leaf (Mangifera indica), and stem banana (Musa spp.), primarily standardized for Reducose®, a patented extract rich in iminosugars such as 1-deoxynojirimycin (DNJ)[1][6]. DNJ acts as a potent inhibitor of alpha-glucosidase enzymes in the gut, reducing carbohydrate absorption, slowing the conversion of starches and sugars to glucose, and promoting healthier postprandial blood glucose and insulin profiles[1][6]. Clinical trials and real-world studies have shown that Reducose® (mulberry extract) in Glucotrojan lowers postprandial blood glucose response by up to 40% when consumed with carbohydrate-rich meals, particularly targeting populations with prediabetes, normoglycemia, and non-insulin-dependent diabetes. The product is intended as a meal companion powder or capsule to be added to foods, drinks, or taken directly[2][4][5][6].

Brand names
GlucotrojanJBA GlucotrojanST. PAUL BRANDS Glucotrojan
Other names
Glucotrojan
02

Targets

Sucrase-Isomaltase

Beyond the preview

Go deeper on Glucotrojan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucotrojan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call